| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/22/2006 | WO2006034106A9 Baff variants and methods therof |
| 06/22/2006 | WO2006032525B1 Combinational therapy for treating cancer |
| 06/22/2006 | WO2006029406A3 Methods for treating bone tumors using bone morphogenic proteins |
| 06/22/2006 | WO2006027701A3 Fas associated factor 1 |
| 06/22/2006 | WO2006027699A3 Rnaiii-inhibiting peptides for treating hiv infection |
| 06/22/2006 | WO2006016247A3 Lysis/resealing process and device for incorporating an active ingredient in erythrocytes |
| 06/22/2006 | WO2006012415A3 Rage protein derivatives |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2006000567A3 Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function |
| 06/22/2006 | WO2005118636A3 Tgf derepressors and uses related thereto |
| 06/22/2006 | WO2005117996A3 Immune response assessment method |
| 06/22/2006 | WO2005108626A3 Mutants of staphylococcal mrs and methods of use |
| 06/22/2006 | WO2005105832A3 Biologically active peptide vapeehptllteaplnpk derivatives |
| 06/22/2006 | WO2005105138A3 Collagen mimics |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005095953A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 6 (ccr6) |
| 06/22/2006 | WO2005091751A3 Novel gene associated with type 1 diabetes and methods of use |
| 06/22/2006 | WO2005085867A8 Screening method for emulators of neural activity and digestive system using gpr35 |
| 06/22/2006 | WO2005074381A3 Induction of apoptosis via arts-iap complexes |
| 06/22/2006 | WO2005065242A3 Method of treating cancer using platelet releasate |
| 06/22/2006 | WO2005046615A3 Compositions for treatment of central nervous system mediated disorders |
| 06/22/2006 | WO2005010030A3 C5a receptor antagonists |
| 06/22/2006 | WO2004094618A3 Modulation of diacylglycerol acyltransferase 1 expression |
| 06/22/2006 | WO2004056318A8 Method for treating amyloid disease |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | US20060135765 Antineoplastic ether lipid compounds |
| 06/22/2006 | US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/22/2006 | US20060135756 Mammalian cell surface antigens; related reagents |
| 06/22/2006 | US20060135753 Modified hemoglobin and methods of making same |
| 06/22/2006 | US20060135751 Human N-type calcium channel isoform and uses thereof |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135748 excellent antimicrobial activity under strong acidic and basic environments, it also shows strong antimicrobial activity against resistant bacteria., it can be used usefully as a natural antimicrobial agent |
| 06/22/2006 | US20060135747 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 06/22/2006 | US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 06/22/2006 | US20060135619 2-[(3-chloro-4-hydroxybenzoyl)amino]-N-[2-(2-methoxyphenyl)ethyl]-5-phenoxybenzamide; therapeutic use as anti-cancer agents, as well as other therapeutic agents, for example, as anti-fertility agents |
| 06/22/2006 | US20060135600 Brain-derived neurotrophic factor (BDNF) and antioxidant Neu 2000 which is 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethylbenzylamino)benzoic acid; synergistic; neuroprotectant |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses |
| 06/22/2006 | US20060135456 Methods and compositions for RNA interference |
| 06/22/2006 | US20060135453 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 06/22/2006 | US20060135450 Combinations of antisense oligonucleotides directed against thymidylate synthase mrna and uses thereof |
| 06/22/2006 | US20060135438 Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux |
| 06/22/2006 | US20060135437 Novel use of peptide compounds for treating pain in trigeminal neuralgia |
| 06/22/2006 | US20060135436 Peptides and methods for the control of obesity |
| 06/22/2006 | US20060135435 Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer |
| 06/22/2006 | US20060135434 New peptides |
| 06/22/2006 | US20060135433 Phenolic binding peptides |
| 06/22/2006 | US20060135432 Peptide antagonists of GnRH-2 that bind to GnRH-2 receptors; useful for the treatment of reproductive diseases and steroid-related cancers |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135430 BLy antagonists and uses thereof |
| 06/22/2006 | US20060135429 Compositions and methods for inducing apoptosis in tumor cells |
| 06/22/2006 | US20060135428 kringle peptides; peptidase stabilized |
| 06/22/2006 | US20060135427 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 06/22/2006 | US20060135426 Long lasting synthetic glucagon like peptide (GLP-1) |
| 06/22/2006 | US20060135425 Administering Desmodus rotundus (DSPA) alpha 1; ischaemia |
| 06/22/2006 | US20060135424 glucagon-like peptide 2 (GLP-2) such as teduglutide and other GLP-2 receptor agonists effective to improve intestinal function particularly in patients presenting with short bowel syndrome with colon-in-continuity |
| 06/22/2006 | US20060135423 Vascular endothelial growth factor (VEGF)-A; macrophage infiltration is reduced inhibiting ocular angiogenesis; chemokine receptor agonists/antagonists; RNA interference; gene expression inhibition; ophthalmology |
| 06/22/2006 | US20060135422 Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
| 06/22/2006 | US20060135421 Unitary combination of FSH and hCG |
| 06/22/2006 | US20060135420 Method of diagnosing non-alcoholic steatohepatitis (nash) using molecular markers |
| 06/22/2006 | US20060135419 Proteins involved in the regulation of energy homeostasis |
| 06/22/2006 | US20060135418 Receptors |
| 06/22/2006 | US20060135417 Use of the crh (corticotropin releasing hormone)-ucn (urocortin) system in the treatment of inflammatory diseases |
| 06/22/2006 | US20060135416 Multifunctional context-activated protides and methods of use |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135414 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 06/22/2006 | US20060135413 Depsipeptide for therapy of kidney cancer |
| 06/22/2006 | US20060135412 Methods for the treatment of alzheimers disease and compositions therefore |
| 06/22/2006 | US20060135411 Administering an effective amount of the compound AcPhe[Orn-Pro-D-Cyclohexylalanine-Trp-Arg] to a subject in need thereof; cyclic peptidic and peptidomimetic compounds have the ability to modulate the activity of G protein-coupled receptors |
| 06/22/2006 | US20060135410 Targeted delivery to legumain-expressing cells |
| 06/22/2006 | US20060135409 Process for and intermediates in the preparation of canfosfamide and its salts |
| 06/22/2006 | US20060135408 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 06/22/2006 | US20060135407 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 06/22/2006 | US20060135406 Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion |
| 06/22/2006 | US20060135405 Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments |
| 06/22/2006 | US20060135404 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/22/2006 | US20060135403 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 06/22/2006 | US20060135402 in combination with oral delivery agent such as N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability |
| 06/22/2006 | US20060135401 Novel method of selecting immunosuppressant having little thrombocytopenic effect |
| 06/22/2006 | US20060134801 Methods and compositions involving MDA-7 |
| 06/22/2006 | US20060134782 Differentiated cells suitable for human therapy |
| 06/22/2006 | US20060134769 Process for producing a virus-inactivated thrombin preparation |
| 06/22/2006 | US20060134737 Ubiquitinated TNF receptor2 and its uses |
| 06/22/2006 | US20060134736 Human growth hormone conjugated with biocompatible polymer |
| 06/22/2006 | US20060134733 Production of functional proteins: balance of shear stress and gravity |
| 06/22/2006 | US20060134634 Human gene |
| 06/22/2006 | US20060134604 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 06/22/2006 | US20060134203 a water insoluble drug (a cyclosporin or macrolides), a solubilizer, and a surfactant; improved stability, and bioavailability; immunosuppressants |
| 06/22/2006 | US20060134201 Collagen troches for treating mouth lesions |
| 06/22/2006 | US20060134186 Oxygenating agents for enhancing host responses to microbial infections |
| 06/22/2006 | US20060134170 Vision enhancing ophthalmic devices and related methods and compositions |
| 06/22/2006 | US20060134167 Administering to the cardiac tissue an angiogenic thrombin derivative peptide and/or inhibiting vascular occulsion or restenosis and stimulating revascularization |
| 06/22/2006 | US20060134144 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 06/22/2006 | US20060134143 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 06/22/2006 | US20060134140 Compositions and methods for treating tumor spreading |
| 06/22/2006 | US20060134130 Oral drug delivery compositions and methods |
| 06/22/2006 | US20060134129 Anticancer agents; leukemia |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134127 Antiallergic agent |
| 06/22/2006 | US20060134126 Peptide constructs for treating disease |